pillbase.ru

Vitekta

Active substance: elvitegravir

elvitegravir

Centralised EU authorisationWithdrawn

Marketing holder: Gilead Sciences International Ltd

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-№(005222)-(РГ-RU)
    Гилеад Сайенсиз Интернешнл Лимитед
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-005722
    Гилеад Сайенсиз Интернешнл Лимитед
US 2
  • Genvoya
    TABLET · ELVITEGRAVIR 150 mg/1, COBICISTAT 150 mg/1, EMTRICITABINE 200 mg/1, TENOFOVIR ALAFENAMIDE FUMARATE 10 mg/1
    61958-1901
    Gilead Sciences, Inc.
  • Stribild
    TABLET, FILM COATED · ELVITEGRAVIR 150 mg/1, COBICISTAT 150 mg/1, EMTRICITABINE 200 mg/1, TENOFOVIR DISOPROXIL FUMARATE 300 mg/1
    61958-1201
    Gilead Sciences, Inc.
Registration
Registration number
EMEA/H/C/002577
Registration status
Withdrawn
ATC code
J05AX11
Sources
  • product · EMA · EMEA/H/C/002577 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002577 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002577 · Verified 2026-10-09